RBFOX2 and adrenal cortex carcinoma: Finally, our analysis of PFI data demonstrated that elevated RBFOX2 levels were correlated with shorter PFI in ACC, BLCA, BRCA, CESC, HNSC, LUAD, and UVM patients (Supplementary Figure S4).